The pancreas is an eggplant-shaped gland about 20 cm long located behind the stomach and sits close to the first section of the small intestine, known as the duodenum. The pancreas is an organ of the digestive system and has both exocrine and endocrine functions:
- The endocrine cells of the pancreas, the Islets of Langerhans (pictured above), are responsible for the production and secretion of the hormones, such as insulin and glucagon. These hormones regulate blood sugar levels.
- The exocrine cells of the pancreas, the acinar cells, secrete pancreatic juice into the duodenum. Pancreatic juice contains digestive enzymes that help digest food, particularly protein.
Pancreatic cancer is an abnormal uncontrolled growth of cells in the pancreas. The cancer begins in the pancreatic ducts and spreads into the body of the pancreas. The surrounding nerves and blood vessels may also be infiltrated with cancerous cells. The cancer can spread to other organs via the lymphatic system.
Pancreatic cancer is often referred to as a ‘silent disease’ as it is frequently diagnosed in the later stages of growth. This is because the pancreas is located behind the stomach and the cancer can remain undetected until it grows large enough to affect nearby organs. The overall survival rates for pancreatic cancer have not changed for almost 50 years. Prognosis is poor for patients with pancreatic cancer.
The causes and symptoms of pancreatic cancer
Unfortunately little is known about the causes of pancreatic cancer, so it can be difficult to explain why some people develop the disease and others don’t. Pancreatic cancer is fundamentally a genetic disease. It can be caused by mutations or changes in a person’s DNA. These mutations may be due to inheriting a faulty gene or these changes can be acquired as we age. Early stages of pancreatic cancer often remain undetected due to lack of significant signs or symptoms. Symptoms are often not noticed until the cancer is large enough to affect nearby organs.
Some earlier signs and symptoms associated with pancreatic cancer may include:
- yellowish skin and eyes, and dark urine, which are caused by a condition known as jaundice, which occurs when the tumour blocks the bile duct into the digestive system
- pain in the upper abdomen or back
- loss of appetite and weight loss
- nausea and vomiting
- change in bowel motions - either diarrhoea or severe constipation
What are the risk factors?
- Age: 80% of cases are diagnosed in people over the age of 60 years. Pancreatic cancer is uncommon in people under 40
- Smoking: doubles your risk
- Chronic pancreatitis: long-term inflammation of the pancreas can increase your risk five-fold
- Diabetes: the association between pancreatic cancer and diabetes is less understood. It is possible that the cancer causes some cases of diabetes, rather than diabetes causing the cancer
- Genetics: there may be a genetic link in up to one in 10 cases of pancreatic cancer. A number of gene mutations can increase your risk: Breast cancer gene 2 (BRCA2), Peutz-Jeghers Syndrome, Familial Atypical Multiple Mole Melanoma (FAMMM), Hereditary Non-Polyposis Colorectal Cancer (HNPCC) and hereditary pancreatitis
Other minor risk factors may include a diet with a high intake of red meat and/or saturated fat, and a reduced intake of fruits and vegetables; and frequent exposure to certain pesticides and petroleum products
Options for pancreatic cancer treatment
Treatment options for pancreatic cancer differ from patient to patient, and are based on several factors, including stage and location of cancer, the age of the patient and general health. Advanced pancreatic cancer can only rarely be treated with the aim of curing the cancer. However, a combination of therapies can be used to prevent the tumour from spreading, to relieve symptoms and to maintain a better quality of life.
There are several treatment options for pancreatic cancer, including surgery, endoscopic treatment, radiotherapy and chemotherapy.
Surgery - the most common surgical procedure is the ‘Whipple’s Procedure’. In this procedure, the head of the pancreas is removed, along with the duodenum, gall bladder, bile duct and part of the stomach. Enough of the pancreas is left to maintain some function. Surgery can also involve the removal of the head and tail of the pancreas, or complete removal of the pancreas, or just the tail, depending on the location of the tumour
Endoscopic treatment - if the tumour is blocking the bile duct, a stent may be inserted to allow bile to drain from the liver
Chemotherapy - chemotherapy, sometimes used in combination with radiotherapy, involves the use of anti-cancer drugs to prevent the cancer cells from dividing
Radiation therapy - radiation therapy uses high-energy x-rays which shrink or destroy cancer cells in the tumour. This therapy may be used to treat cancer that has not spread but cannot be removed with surgery. It may also be used to relieve symptoms. The most common form used to treat pancreatic cancer is external beam radiation therapy
Garvan's research into pancreatic cancer
Established in 2008, the International Cancer Genome Consortium (ICGC) brings together leading cancer researchers across the world, through 11 funding organisations in 12 countries, and aims to catalogue the genetic changes of the 50 most common cancers. Garvan is making a substantial contribution to the ICGC by tackling pancreatic cancer.
The Australian Pancreatic Cancer Genome Initiative (APGI) is the Australian arm of the international consortium. Together with collaborators from the Institute of Molecular Biosciences in Brisbane, and other specialists, Garvan researchers are looking to examine genes from 400 pancreatic tumour samples with the aim of determining the exact genetic aberrations in each tumour. This information will help us determine why some drug treatments work and why others do not, and will help researchers to design new drug therapies to specifically target the genetic aberrations in each tumour.
The information from this study, and in all of the ICGC projects, will be made freely available on the internet and will help the development of new diagnostic tools and targeted therapies for pancreatic cancer patients.
Please help us continue our breakthrough medical research